Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

Por Tsai, J. N., Uihlein, A. V., Burnett-Bowie, S. M., Neer, R. M., Derrico, N. P., Lee, H., Bouxsein, M. L., Leder, B. Z.
Publicado no J Clin Endocrinol Metab (2016)